N1-Methyl-2-pyridone-5-carboxamide

N1-Methyl-2-pyridone-5-carboxamide
Names
	Preferred IUPAC name 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide
	Other names Nudifloramide; 6-Keto-1-methyl-nicotinamide
Identifiers
CAS Number	701-44-0;
3D model (JSmol)	Interactive image;
3DMet	B00866;
ChEBI	CHEBI:27410;
ChEMBL	ChEMBL3542314;
ChemSpider	62899;
KEGG	C05842;
PubChem CID	69698;
UNII	68139USC7W;
CompTox Dashboard (EPA)	DTXSID70220374 ;
	InChI InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11) Key: JLQSXXWTCJPCBC-UHFFFAOYSA-N;
	SMILES CN1C=C(C=CC1=O)C(=O)N;
Properties
Chemical formula	C7H8N2O2
Molar mass	152.153 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

N1-Methyl-2-pyridone-5-carboxamide (also known as 1-methyl-6-oxopyridine-3-carboxamide or nudifloramide and abbreviated as 2PY, 2-Py or NMPC) is one of a number of metabolic products of nicotinamide adenine dinucleotide (NAD) degradation.^[1]^[2]^[3]^[4] The presence of 2PY in human blood serum can be an indication of poor kidney performance or chronic kidney disease.^[2]^[3] 2PY has been identified as a product of the metabolism of caffeine and niacin.^[5]

2PY's molecular formula is C₇H₈N₂O₂ and its molecular weight 152.153 g/mol.^[2]

References[edit]

^ Shibata, Katsumi; Kawada, Teruo; Iwai, Kazuo (1988). "Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-3-carboxamide, by high-performance liquid chromatography". Journal of Chromatography B. 424 (1): 23–28. doi:10.1016/S0378-4347(00)81072-5. PMID 2966806.
^ ^a ^b ^c "1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide". PubChem. US National Institutes of Health. Retrieved 20 February 2019.
^ ^a ^b Rutkowski, Boleslaw (2003). "N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?". Kidney International. 63 (84): S19–S21. doi:10.1046/j.1523-1755.63.s84.36.x. PMID 12694300.
^ Grison, Stephan (2016). "Metabolomics reveals dose effects of low-dose chronic exposure to uranium in rats: identification of candidate biomarkers in urine samples". Metabolomics. 12 (10): 154. doi:10.1007/s11306-016-1092-8. PMC 5025510. PMID 27729830.
^ Wong, Pierre; Bachki, Abderrazak; Banerjee, Kris; Leyland-Jones, Brian (2002). "Identification of N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-5-carboxamide as components in urine extracts of individuals consuming coffee". Journal of Pharmaceutical and Biomedical Analysis. 30 (3): 773–780. doi:10.1016/S0731-7085(02)00384-9. PMID 12367703.

This article about chemical compounds is a stub. You can help Wikipedia by expanding it.

[shibata-1] Shibata, Katsumi; Kawada, Teruo; Iwai, Kazuo (1988). "Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-3-carboxamide, by high-performance liquid chromatography". Journal of Chromatography B. 424 (1): 23–28. doi:10.1016/S0378-4347(00)81072-5. PMID 2966806.

[pubchem-2] "1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide". PubChem. US National Institutes of Health. Retrieved 20 February 2019.

[rutkowski-3] Rutkowski, Boleslaw (2003). "N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?". Kidney International. 63 (84): S19–S21. doi:10.1046/j.1523-1755.63.s84.36.x. PMID 12694300.

[grison2016-4] Grison, Stephan (2016). "Metabolomics reveals dose effects of low-dose chronic exposure to uranium in rats: identification of candidate biomarkers in urine samples". Metabolomics. 12 (10): 154. doi:10.1007/s11306-016-1092-8. PMC 5025510. PMID 27729830.

[wong-5] Wong, Pierre; Bachki, Abderrazak; Banerjee, Kris; Leyland-Jones, Brian (2002). "Identification of N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-5-carboxamide as components in urine extracts of individuals consuming coffee". Journal of Pharmaceutical and Biomedical Analysis. 30 (3): 773–780. doi:10.1016/S0731-7085(02)00384-9. PMID 12367703.

[1]

[2]

[3]

[4]

[5]